scispace - formally typeset
A

Amine Belaid

Researcher at French Institute of Health and Medical Research

Publications -  23
Citations -  6125

Amine Belaid is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Autophagy & Cancer. The author has an hindex of 13, co-authored 20 publications receiving 5567 citations. Previous affiliations of Amine Belaid include University of Nice Sophia Antipolis & Brigham and Women's Hospital.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC.

TL;DR: Two plasma miRNAs expression profiles in plasma may be useful for predicting the outcome of patients with resectable NSCLC, and a three-miRNA plasma signature significantly predicted survival of squamous cell carcinoma patients.
Journal ArticleDOI

Cadmium-induced autophagy in rat kidney: an early biomarker of subtoxic exposure.

TL;DR: It is suggested that kidney cortex adapts to subtoxic Cd dose by activating autophagy, a housekeeping process that ensures the degradation of damaged proteins, given that Cd is persistent within cytosol, it might damage proteins continuously and impair at long-term autophile efficiency.
Journal ArticleDOI

mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability

TL;DR: It is found that pharmacological inhibitors of guanylate nucleotide synthesis have selective deleterious effects on TSC-deficient cells, including in mouse tumor models, revealing a metabolic vulnerability downstream of mTORC1 triggered by anabolic imbalance.